Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
January 30, 2026
The Regularized Horseshoe for Covariate Selection Improves Convenience and Predictive Performance in Population PK/PD Models
Arya Pourzanjani, Casey Davis
Plos One
|
April 7, 2016
Adherent Use of Digital Health Trackers Is Associated with Weight Loss
Arya Pourzanjani, Tom Quisel, Luca Foschini
Plos One
|
September 29, 2015
On the Inference of Functional Circadian Networks Using Granger Causality
Arya Pourzanjani, Erik D Herzog, Linda R Petzold
CPT: Pharmacometrics & Systems Pharmacology
|
May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studies
Arya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
January 30, 2026
The Regularized Horseshoe for Covariate Selection Improves Convenience and Predictive Performance in Population PK/PD Models
Arya Pourzanjani, Casey Davis
Plos One
|
April 7, 2016
Adherent Use of Digital Health Trackers Is Associated with Weight Loss
Arya Pourzanjani, Tom Quisel, Luca Foschini
Plos One
|
September 29, 2015
On the Inference of Functional Circadian Networks Using Granger Causality
Arya Pourzanjani, Erik D Herzog, Linda R Petzold
CPT: Pharmacometrics & Systems Pharmacology
|
May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studies
Arya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
Page
of 1